An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.

Cryptococcosis is a lethal mycosis instigated by the pathogenic species Cryptococcus neoformans and Cryptococcus gattii, primarily affects the lungs, manifesting as pneumonia, and the brain, where it presents as meningitis. Mortality rate could reach 100% if infections remain untreated in cryptococc...

Full description

Saved in:
Bibliographic Details
Main Authors: Md Razwan Sardar Sami, Nurul Amin Rani, Mohammad Mahfuz Enam Elahi, Mohammad Sajjad Hossain, Minhaz Abdullah Al Mueid, Zahidur Rahim, Rajesh B Patil, Abu Tayab Moin, Israt Jahan Bithi, Sabekun Nahar, Israt Jahan Konika, Sneha Roy, Jannatul Aleya Preya, Jamil Ahmed
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0315105
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850151234070118400
author Md Razwan Sardar Sami
Nurul Amin Rani
Mohammad Mahfuz Enam Elahi
Mohammad Sajjad Hossain
Minhaz Abdullah Al Mueid
Zahidur Rahim
Rajesh B Patil
Abu Tayab Moin
Israt Jahan Bithi
Sabekun Nahar
Israt Jahan Konika
Sneha Roy
Jannatul Aleya Preya
Jamil Ahmed
author_facet Md Razwan Sardar Sami
Nurul Amin Rani
Mohammad Mahfuz Enam Elahi
Mohammad Sajjad Hossain
Minhaz Abdullah Al Mueid
Zahidur Rahim
Rajesh B Patil
Abu Tayab Moin
Israt Jahan Bithi
Sabekun Nahar
Israt Jahan Konika
Sneha Roy
Jannatul Aleya Preya
Jamil Ahmed
author_sort Md Razwan Sardar Sami
collection DOAJ
description Cryptococcosis is a lethal mycosis instigated by the pathogenic species Cryptococcus neoformans and Cryptococcus gattii, primarily affects the lungs, manifesting as pneumonia, and the brain, where it presents as meningitis. Mortality rate could reach 100% if infections remain untreated in cryptococcal meningitis. Treatment options for cryptococcosis are limited and and there are no licensed vaccines clinically available to treat or prevent cryptococcosis. Our study utilizes an integrated bioinformatics approaches to develop a polyvalent multiepitope subunit vaccine focusing on the key virulent proteins Heat shock transcription factor and Chaperone DnaK of both C. neoformans and C. gatti. Then in silico analysis was done to predict highly antigenic epitopes by assessing antigenicity, transmembrane topology screening, allergenecity, toxicity, and molecular docking approaches. Following this analysis, we designed two vaccine constructs integrating a compatible adjuvant and suitable linkers. These constructs exhibited notable characteristics including high antigenicity, non-toxicity, solubility, stability, and compatibility with Toll-like receptors (TLRs). The interaction between both vaccine constructs and TLR2, TLR3, and TLR9 was assessed through molecular docking analysis. Molecular dynamics simulations and MM-PBSA calculations suggest the substantial stabilizing property and binding affinity of Vaccine Construct V1 against TLR9. Both the vaccines revealed to have a higher number of interchain hydrogen bond with TLR9. These findings serve as a crucial stepping stone towards a comprehensive solution for combating cryptococcus infections induced by both C. neoformans and C. gattii. Further validation through in vivo studies is crucial to confirm the effectiveness and potential of the vaccine to curb the spread of cryptococcosis. Subsequent validation through in vivo studies is paramount to confirm the effectiveness and potential of the vaccine in reducing the spread of cryptococcosis.
format Article
id doaj-art-30b41ecf7ba24c2ea431232e7e65eb52
institution OA Journals
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-30b41ecf7ba24c2ea431232e7e65eb522025-08-20T02:26:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031510510.1371/journal.pone.0315105An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.Md Razwan Sardar SamiNurul Amin RaniMohammad Mahfuz Enam ElahiMohammad Sajjad HossainMinhaz Abdullah Al MueidZahidur RahimRajesh B PatilAbu Tayab MoinIsrat Jahan BithiSabekun NaharIsrat Jahan KonikaSneha RoyJannatul Aleya PreyaJamil AhmedCryptococcosis is a lethal mycosis instigated by the pathogenic species Cryptococcus neoformans and Cryptococcus gattii, primarily affects the lungs, manifesting as pneumonia, and the brain, where it presents as meningitis. Mortality rate could reach 100% if infections remain untreated in cryptococcal meningitis. Treatment options for cryptococcosis are limited and and there are no licensed vaccines clinically available to treat or prevent cryptococcosis. Our study utilizes an integrated bioinformatics approaches to develop a polyvalent multiepitope subunit vaccine focusing on the key virulent proteins Heat shock transcription factor and Chaperone DnaK of both C. neoformans and C. gatti. Then in silico analysis was done to predict highly antigenic epitopes by assessing antigenicity, transmembrane topology screening, allergenecity, toxicity, and molecular docking approaches. Following this analysis, we designed two vaccine constructs integrating a compatible adjuvant and suitable linkers. These constructs exhibited notable characteristics including high antigenicity, non-toxicity, solubility, stability, and compatibility with Toll-like receptors (TLRs). The interaction between both vaccine constructs and TLR2, TLR3, and TLR9 was assessed through molecular docking analysis. Molecular dynamics simulations and MM-PBSA calculations suggest the substantial stabilizing property and binding affinity of Vaccine Construct V1 against TLR9. Both the vaccines revealed to have a higher number of interchain hydrogen bond with TLR9. These findings serve as a crucial stepping stone towards a comprehensive solution for combating cryptococcus infections induced by both C. neoformans and C. gattii. Further validation through in vivo studies is crucial to confirm the effectiveness and potential of the vaccine to curb the spread of cryptococcosis. Subsequent validation through in vivo studies is paramount to confirm the effectiveness and potential of the vaccine in reducing the spread of cryptococcosis.https://doi.org/10.1371/journal.pone.0315105
spellingShingle Md Razwan Sardar Sami
Nurul Amin Rani
Mohammad Mahfuz Enam Elahi
Mohammad Sajjad Hossain
Minhaz Abdullah Al Mueid
Zahidur Rahim
Rajesh B Patil
Abu Tayab Moin
Israt Jahan Bithi
Sabekun Nahar
Israt Jahan Konika
Sneha Roy
Jannatul Aleya Preya
Jamil Ahmed
An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.
PLoS ONE
title An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.
title_full An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.
title_fullStr An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.
title_full_unstemmed An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.
title_short An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.
title_sort immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi epitope vaccine against cryptococcosis
url https://doi.org/10.1371/journal.pone.0315105
work_keys_str_mv AT mdrazwansardarsami animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT nurulaminrani animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT mohammadmahfuzenamelahi animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT mohammadsajjadhossain animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT minhazabdullahalmueid animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT zahidurrahim animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT rajeshbpatil animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT abutayabmoin animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT isratjahanbithi animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT sabekunnahar animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT isratjahankonika animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT sneharoy animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT jannatulaleyapreya animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT jamilahmed animmunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT mdrazwansardarsami immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT nurulaminrani immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT mohammadmahfuzenamelahi immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT mohammadsajjadhossain immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT minhazabdullahalmueid immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT zahidurrahim immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT rajeshbpatil immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT abutayabmoin immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT isratjahanbithi immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT sabekunnahar immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT isratjahankonika immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT sneharoy immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT jannatulaleyapreya immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis
AT jamilahmed immunoinformaticsandextensivemoleculardynamicsstudytodevelopapolyvalentmultiepitopevaccineagainstcryptococcosis